Serum anti-Müllerian hormone levels are lower in reproductive-age women with Crohn's disease compared to healthy control women
article
OA: closed
CC0
⤵ 7 in-corpus citations
Abstract
BACKGROUND AND AIM: Crohn's disease (CD) decreases fertility both directly, by inducing inflammation in the fallopian tubes and ovaries, and indirectly, through the surgical interventions and tubal adhesions associated with disease treatment. Anti-müllerian hormone (AMH) is a reliable indicator of ovarian reserve in women. We aimed to compare serum AMH levels between reproductive-age women with CD and healthy controls. METHODS: Serum AMH levels were measured by ELISA in 35 women with CD and 35 age-matched healthy women controls. RESULTS: CD patients and controls were similar in terms of age, height, weight and BMI. Mean CD duration was 60 months. CRP, ESR and leukocyte counts were significantly higher in CD patients compared to the controls (p<0.001, p=0.004 and p=0.04, respectively). AMH levels in CD patients (1.02 ± 0.72) were significantly lower compared to the controls (1.89 ± 1.80) (p = 0.009). Serum AMH levels in CD patients with active disease (0.33 ± 0.25) were significantly lower compared to CD patients who were in remission (1.53 ± 0.49) (p = 0.001). Serum AMH levels were similar in CD patients with a disease duration of less than 5 years (17 patients) and CD patients with a disease duration of greater than 5 years (18 patients) (p = 0.8). In CD patients, a negative correlation between CDAI and serum AMH levels was found (r = -0.718, p < 0.001). Serum AMH levels were similar in CD patients who had (6 patients) and had not undergone (29 patients) surgical treatment (p = 0.2). CONCLUSION: Serum AMH levels of reproductive-age women with CD were significantly lower compared to the controls. CDAI and AMH are inversely correlated.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (37)
- doi:10.1136/gut.27.7.821 via openalex
- W10339549 via openalex
- doi:10.1080/110241501750069800 via openalex
- doi:10.1007/bf02055604 via openalex
- doi:10.1016/s0015-0282(01)02993-4 via openalex
- doi:10.1007/bf00699417 via openalex
- doi:10.1007/bf02051924 via openalex
- doi:10.1093/humrep/del421 via openalex
- doi:10.1016/j.crohns.2009.09.009 via openalex
- doi:10.1038/sj.bjc.6603814 via openalex
- doi:10.1111/j.1572-0241.1998.00698.x via openalex
- doi:10.1016/s0140-6736(79)90292-7 via openalex
- doi:10.1046/j.1365-2168.1999.01076.x via openalex
- doi:10.1053/gast.2001.28692 via openalex
- doi:10.1136/gut.22.6.452 via openalex
- doi:10.1007/s10350-004-6411-x via openalex
- W6600397425 via openalex
- doi:10.1038/ajg.2009.579 via openalex
- doi:10.1016/j.fertnstert.2010.10.011 via openalex
- doi:10.1136/gut.25.10.1078 via openalex
- doi:10.1080/00365529950173069 via openalex
- doi:10.1016/s0015-0282(99)00639-1 via openalex
- doi:10.1210/jc.2006-0331 via openalex
- doi:10.1016/j.fertnstert.2004.03.061 via openalex
- doi:10.1177/0961203311409272 via openalex
- doi:10.1093/humupd/dml034 via openalex
- doi:10.1016/j.fertnstert.2007.12.013 via openalex
- doi:10.1093/humrep/den108 via openalex
- doi:10.1053/gast.2002.30345 via openalex
- doi:10.1016/s0020-7292(97)00088-x via openalex
- doi:10.1016/s0015-0282(16)44000-8 via openalex
- doi:10.1097/00004836-198908000-00011 via openalex
- doi:10.1007/bf02052444 via openalex
- doi:10.1016/0016-5085(90)90617-a via openalex
- doi:10.1007/s10815-011-9589-6 via openalex
- doi:10.1016/j.fertnstert.2008.08.123 via openalex
- doi:10.1080/110241501317076245 via openalex
Cited by (7)
- Comparison of serum anti-Müllerian hormone between unilateral and bilateral ovarian endometriomas during follicular, luteal, and random menstrual phases: a retrospective study 2023
- Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis 2023
- Serum anti-Müllerian hormone recovery after ovarian cystectomy for endometriosis: A retrospective study among Korean women 2022
- Ovarian reserve assessment in crohn patients of reproductive age 2021
- Ovarian Reserve Assessed by the Anti-Mullerian Hormone and Reproductive Health Parameters in Women With Crohn´s Disease, a Case-Control Study 2021
- Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease 2020
- Antimullerian Hormone Level and Endometrioma Ablation Using Plasma Energy 2014
Source provenance
- openalex
- last seen: 2026-05-11T05:40:41.230350+00:00
License: CC0
· commercial use OK